The association between time in the glucose target range and abnormal ankle-brachial index: a cross-sectional analysis

Table 2 Clinical characteristics of low, normal, and high ABI groups

	Total	Low ABI	Normal ABI	High ABI	χ²/t/z	P
N	405	20	323	62
TIR (3.9–10 mmol/L) (%)	72.96 (52.28,85.56)	67.77 (46.05,83.93)	74.00 (56.00,86.15)	61.17 (42.15,80.99)	9.527	0.009
TAR% (> 10 mmol/L) (%)	26.41 (13.40,46.93)	31.93 (15.06,53.95)	25.67 (13.08,43.26)	36.52 (14.38,57.85)	6.750	0.034
MBG (mmol/L)	8.83 (7.88,10.31)	9.04 (7.95,10.76)	8.76 (7.83,10.04)	9.91 (8.23,10.88)	6.251	0.044
SD (mmol/L)	2.31 (1.76,2.95)	2.59 (1.59,3.08)	2.31 (1.77,2.94)	2.28 (1.75,3.12)	0.151	0.927
MODD (mmol/L)	2.04 (1.47,2.77)	2.10 (1.48,2.99)	2.04 (1.45,2.76)	2.00 (1.50,3.00)	0.096	0.953
MAGE (mmol/L)	4.48 (3.39,5.59)	3.80 (3.37,5.88)	4.55 (3.39,5.67)	4.38 (3.28,5.15)	0.735	0.693
ADDR (mmol/L)	21.80 (15.31,29.58)	20.24 (14.60,29.19)	21.37 (15.47,29.25)	24.92 (15.18,31.64)	1.446	0.485
M value (mmol/L)	6.64 (3.04,12.22)	7.59 (2.78,13.47)	6.20 (3.01,11.59)	10.10 (3.44,17.32)	5.215	0.074
CV[M (QL, QU)]	0.25 (0.21,0.32)	0.25 (0.18,0.34)	0.26 (0.21,0.32)	0.25 (0.20,0.29)	1.229	0.541

^aTIR: time in range; TAR: time above range; MBG: mean blood glucose; SD: standard deviation; MODD: mean of daily differences; MAGE: mean amplitude of glucose excursions; ADDR: average daily risk range; CV: coefficient of variation
^bContinuous data with normal distribution were expressed in mean ± SD, and inter-group comparison was performed by one-way ANOVA. Abnormal distribution measurement data were expressed as medians (lower and upper quartiles) [M (QL, QU)], and variables among multiple groups were compared by non-parametric Kruskal-Wallis test. The categorical variables were expressed as count (percentages) [N (%)] and χ2 test for which was used
The bolded values in the table highlight results with P value < 0.05

ISSN: 1475-2840